You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma

 

Online download statistics by month:

Online download statistics by month: October 2021 to July 2025

AbstractFullPdf
Oct 202119019039
Nov 2021425424331
Dec 202113713973
Jan 20229510055
Feb 2022220244161
Mar 20229910367
Apr 202210611254
May 2022778332
Jun 202211412233
Jul 202212613033
Aug 202214114518
Sep 202212212321
Oct 202211111736
Nov 202212212555
Dec 2022747726
Jan 2023646639
Feb 202311011034
Mar 2023646637
Apr 2023475031
May 2023737327
Jun 2023525223
Jul 2023797953
Aug 2023727225
Sep 2023434422
Oct 2023545412
Nov 2023606118
Dec 2023707228
Jan 2024404125
Feb 2024515127
Mar 20245454193
Apr 2024666618
May 2024596140
Jun 2024333320
Jul 2024616432
Aug 2024424120
Sep 2024363717
Oct 2024586032
Nov 2024757628
Dec 2024555722
Jan 2025868633
Feb 2025636326
Mar 2025747536
Apr 2025626223
May 2025343421
Jun 2025353616
Jul 2025220
Total393340322012